New device may ease swelling in head and neck cancer survivors

NCT ID NCT04797390

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether an advanced pneumatic compression device (Flexitouch Plus) could reduce swelling and symptoms in 236 head and neck cancer survivors with lymphedema. Participants either used the device daily or received usual care like manual drainage and compression garments. The trial measured changes in internal and external swelling, symptom burden, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Advanced Pneumatic Compression Device (Flexitouch Plus)
What this could lead to
If it works, this could offer a more effective way to reduce swelling and improve quality of life for head and neck cancer survivors with lymphedema.
What could go wrong
This is a completed trial, but results may not apply to all patients. The device is an add-on to usual care, not a standalone cure, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Advanced Head & Neck Rehabilitation Center of Texas

    Fort Worth, Texas, 76104, United States

  • Johns Hopkins University

    Baltimore, Maryland, 21205, United States

  • Karmanos Cancer Institute

    Detroit, Michigan, 48201, United States

  • Montefiore Medical Center

    The Bronx, New York, 10467, United States

  • Richmond University Medical Center

    Staten Island, New York, 10310, United States

  • Rush University Medical Center

    Chicago, Illinois, 60612, United States

  • University of Alabama

    Birmingham, Alabama, 35924, United States

  • University of Louisville

    Louisville, Kentucky, 40202, United States

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.